Oxford Capital sells medtech specialist

Orthomimetics, a Cambridge-based medical technology company, has been sold by UK VC firm Oxford Capital to TiGenix, a Belgian biomedical business.

The deal values Orthomimetics at €16m.

Orthomimetics was founded in 2005 as a spin-out from the University of Cambridge and the Massachusetts Institute of Technology. It closed a series A round in December 2006, raising £5.65m from Schroders, Caravel Capital, Sloane Robinson and Oxford Capital Partners.